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1 6aaaIins 285 i 116 S3e * 261
Sefore 2AD 304 * 162* 1066 i 601”
2 6aeelins 392 * 179 S69 + 356
10 min 485 * 217** 7S6 & 271”’
*p> 0.05,l*p <0.05











ATP-sensitiveK+ channelopeners havebeenshownto decreaseAPDin
cardiactissue.We thereforetestadthe hypothesisthat nicorandil(N),an
openerof IKATP,haveanyantiarrhythmiceffectson classIll antiarrhythmic
drug-inducedventriculararrhythmias.In 10anesthetizeddogswithchronic
atrioventricularblock,werecordedmonophaaicactionpotentials(MAP)from
the left (LV)and rfghtventricular(RV)endocardiumwithcontactelectrode
cethaters.AnovelclassIll antiarrhythmicdrug,MS-551(MS,2-6 mg/Kg)was
administeredovera periodof 10 minutes.Tenminuteslater,N (1.0m~Kg)
wasadministeredin threa minutes.MSdecreasedventricularescaperate
from76* 6/reinto.45 10/minand increasedRVMAPduration(MAPD)
from217+32 maaoto308+2 mseo(p < 0.01)andLVMAPDfrom232+32
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dapsndantblockof Iaus(36.8 + 3.1%)whereaait enhancedItol (9.1 &
8.1%)andhadno aignifioanteffecton the globalcurrant(n = 29).A higher
concentrationof BT (50 YM) induceda uae-dependentblink of Itol and
almostabolishedIeua.BT(10PM)washoutwasassociatedwithanincrease
in Itol (23.1 + 10.8%)and global current(19.8 + 6.56A),whereasIsus
remainedsuppressed.Totest whetherBT actedon distinctchannelsites,
the drug (10 PM) was appliedintracellularlythroughthe patohpipettefor
10 to 20 min.This induceda large increasein both Itol (78 + 14%)and
globalcurrant(28.7+ 8.4%)and inhibitedIaus(28.9+ 6.3%).Thiaeffeol
was characterizedby a shift towardsnegativepotentialsof the activation
curveand~ increaaain maximalconductanceof Itol. Incelladialysadwith












in heartat nM Ooncenttations,Mutationsin IKrcausea form of Long QT




a singlebindingsiteon eachcell type(LYM:Kd2.6 & 0.9 x 1O-sM, Bmax
61+33 fmol/l@; N= 6 andPMN:Kd3.3+ 1.6x 10-6M,Bmax163+ 109
fmol/lOE;N = 6). Wethenasseasadwhetherdrugaknownto blockiK,(e.g.




E-4031 0.4*0.1 4* 1“ 5&1*
Sotslol 14+7 27 i 3 27&4
Lidocains 360*220 395+ 361 1922 * 1054
Verapamil >300 8*I* 15+1”
The meanICWvaluesfor inhibitionof bindingto the highaffinityaite in
bothLYMandPMNreasonablycorrelatedwithall of the teatadcompounda
exceptE4031 andverspamil.ThetwodisparateICmvalues(*p e 0.01as
comparedwithmyocytes)indicatethat in humanwhiteblood0s11sdofetilide













a 56bipolarelectrodemappingsyatem.A24 astepdecreasein interetimulua
interval(ISI)from1.0to 0.3s eliciteda rnono-exponantialdecreasein 82(N)
withanapparentdruguptakerate,A*.A24astepincreasein iSi from0.3to
1.0aeliciteda aaoondmonoexponentialincreasein82(N)withananalogous
apparentdrugdeclinerate,RA*.Exploitingthe approximationthat A* and
RA*are identicaliinearfunctionsof the recoveryinterval(t, whare$ = 1S1–
APDW)auchthat Fu* ===A* = AaG+ k+, (where& is the activatedstate
druguptakerate,A, is the reatingetata drug uptakerate,and ~ ia 0.001
s) the apparentfundamentalrateconstantsfor FLEC(N = 4) bindingand
unbindingfromtheactivated(k, la)andresting(k, l,)stateaweremmparad
withQUIN(N= 14)(FLECvsQUIN,mean+ SD):ks=4.9+ 2.7vs6.7+ 3.9
x 106M-’ s-’, la=5.9 + 5.5va72+ 29s-l, k,=5.5 + 3.1vs 10.6+8.9 x





for the differentialresponseof FLECandQUINto rapidtachyoerdiaa.Thia








rectificationandisbelievedto benegligibleat potentialspositiveto -40 mV.
Thepresentstudywaadasignadto avaluateiKl duringthe aOtiOn potential
(AP)in dogventricularmyocyteswiththe whole-cellpatch-clamptechnique
at36W.Waappliedcurrent-clampmodeto recordAPa,andvoltage-andAP-
